Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Exelixis, Inc. (EX9.F)

Compare
37.01
-0.82
(-2.17%)
As of 12:39:14 PM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,168,701
2,168,701
1,830,208
1,611,062
1,434,970
Cost of Revenue
76,216
76,216
72,547
57,909
52,873
Gross Profit
2,092,485
2,092,485
1,757,661
1,553,153
1,382,097
Operating Expense
1,402,536
1,402,536
1,586,776
1,351,669
1,095,431
Operating Income
689,949
689,949
170,885
201,484
286,666
Net Non Operating Interest Income Expense
77,156
77,156
86,543
33,065
7,672
Other Income Expense
-85,465
-85,465
93
-197
-184
Pretax Income
681,640
681,640
257,521
234,352
294,154
Tax Provision
160,373
160,373
49,756
52,070
63,091
Net Income Common Stockholders
521,267
521,267
207,765
182,282
231,063
Diluted NI Available to Com Stockholders
521,267
521,267
207,765
182,282
231,063
Basic EPS
1.80
--
0.65
0.56
0.73
Diluted EPS
1.76
--
0.65
0.56
0.72
Basic Average Shares
290,030
--
318,151
324,556
314,884
Diluted Average Shares
296,132
--
321,464
324,556
322,359
Total Operating Income as Reported
604,617
604,617
170,885
201,484
286,666
Total Expenses
1,478,752
1,478,752
1,659,323
1,409,578
1,148,304
Net Income from Continuing & Discontinued Operation
521,267
521,267
207,765
182,282
231,063
Normalized Income
586,545.98
586,545.98
207,765
182,282
231,063
Interest Income
77,156
77,156
86,543
33,065
7,672
Net Interest Income
77,156
77,156
86,543
33,065
7,672
EBIT
689,949
689,949
170,885
201,484
286,666
EBITDA
718,752
718,752
196,602
222,359
300,296
Reconciled Cost of Revenue
76,216
76,216
72,547
57,909
52,873
Reconciled Depreciation
28,803
28,803
25,717
20,875
13,630
Net Income from Continuing Operation Net Minority Interest
521,267
521,267
207,765
182,282
231,063
Total Unusual Items Excluding Goodwill
-85,332
-85,332
--
--
--
Total Unusual Items
-85,332
-85,332
--
--
--
Normalized EBITDA
804,084
804,084
196,602
222,359
300,296
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-20,053.02
-20,053.02
--
--
--
12/31/2021 - 4/19/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

50BA.F Bicycle Therapeutics plc
9.65
-4.46%
 
6XP.SG Xspray Pharma AB (publ)
2.8000
+1.08%
 
471A.F aTyr Pharma, Inc.
3.1400
-16.04%
 
GBM.F Inovio Pharmaceuticals, Inc.
1.7500
-6.91%
 
0M4.F Mersana Therapeutics, Inc.
0.5398
+27.64%
 
7UM.F Ultimovacs ASA
0.1670
-18.93%
 
22Z.F Zealand Pharma A/S
75.20
-6.79%
 
4YL.F Nanoform Finland Oyj
1.1600
+1.75%
 
5CV.F CureVac N.V.
2.8660
-1.17%
 
CARA Cara Therapeutics, Inc.
4.5200
-2.38%